SOPHiA GENETICS (SOPH) Operating Income (2020 - 2026)

SOPHiA GENETICS has disclosed Operating Income across 7 years of filings, most recently posting -$20.1 million for Q2 2026.

• In Q2 2026, Operating Income fell 8.44% year-over-year to -$20.1 million; the TTM figure through Jun 2026 stood at -$73.7 million (down 9.47% YoY), while the FY2025 annual figure was -$70.9 million, down 6.52% from the prior year.
• Operating Income came in at -$20.1 million for Q2 2026 at SOPHiA GENETICS, down from -$17.3 million in the prior quarter.
• In the past five years, Operating Income ranged from a high of -$15.0 million in Q2 2024 to a low of -$25.0 million in Q1 2022.
• Average Operating Income over 5 years is -$18.7 million, with a median of -$18.5 million recorded in 2025.
• Year-over-year, Operating Income tumbled 78.03% in 2022 and soared 30.01% in 2023.
• Over 5 years, Operating Income stood at -$15.1 million in 2022, then retreated by 25.61% to -$18.9 million in 2023, then advanced by 7.93% to -$17.4 million in 2024, then decreased by 6.15% to -$18.5 million in 2025, then fell by 8.3% to -$20.1 million in 2026.
• Per Business Quant data, the three most recent Operating Income figures were -$20.1 million in Q2 2026, -$17.3 million in Q1 2026, and -$18.5 million in Q4 2025.